Biomarker concentrations in serum samples were analysed using the V-PLEX Neuroinflammation Panel 1 Human Kit (Meso Scale Diagnostics (MSD), Gaithersburg, Maryland, USA) on a
MESO QuickPlex SQ 120 instrument (MSD) according to the manufacturer′s specifications. Sample values below the detection limit of the assay were assigned a value of the detection limit divided by √2.16 If more than 30% of the measured samples for any given biomarker were below the detection limit, the biomarker was excluded from the analysis. Likewise, samples with a coefficient of variation>30% between duplicate measurements were excluded from the analysis (
online supplemental table 1). Biomarkers on the panel included: IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12/IL-23p40, IL-13, IL-15, IL-16, IL-17A, interferon (IFN)-γ, tumour necrosis factor (TNF)-α, TNF-β, eotaxin, eotaxin-3, IFN-γ-induced protein (IP)-10, monocyte chemoattractant protein (MCP)−1, MCP-4, macrophage-derived chemokine (MDC), macrophage inflammatory protein (MIP)-1α, MIP-1β, thymus and activation regulated chemokine (TARC), and CRP.
Okdahl T., Wegeberg A.M., Pociot F., Brock B., Størling J, & Brock C. (2022). Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic. BMJ Open, 12(12), e062188.